Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Director/PDMR Shareholding

27 Nov 2015 10:00

RNS Number : 2011H
Creston PLC
27 November 2015
 

27 November 2015

 

 

Creston plc

 

 

 

('Creston' or the 'Group')

 

Grant of Awards to Executive Directors under the Long Term Incentive Plan

 

Creston plc (LSE: CRE) announces that, on 27 November 2015, the Group granted the following conditional share awards (the "Awards") to the Executive Directors under the Creston Long Term Incentive Plan 2015 ("LTIP") approved by shareholders at the 2015 Annual General Meeting. The Awards were granted at a share price of 121.75 pence per ordinary share (being the average of the middle market quotations of the Company's shares during a period of 3 dealing days immediately prior to the date of grant) as set out below:

 

Name

Award Type

Number of ordinary shares subject to LTIP Award

Market value of shares at the date of the Award (£)

Barrie Brien

Core Award

312,114

380,000

Barrie Brien

Stretch Award

312,114

380,000

Kathryn Herrick

Core Award

94,455

115,000

Kathryn Herrick

Stretch Award

94,455

115,000

 

After granting the Awards the Executive Directors now hold the following beneficial interests:

 

Name

Number of conditional shares held following Award

Number of ordinary shares currently held

Total shareholding of currently held shares (%)

Barrie Brien

1,156,118

355,230

0.61%

Kathryn Herrick

292,196

5,700

0.01%

 

The conditional shares granted under the Awards will normally vest on 12 June 2018, subject to the satisfaction of the stretching performance conditions applying to the respective Core and Stretch Awards and are then required to be held for a further two years.

 

The performance criteria for which the Core Awards are based on is the performance of the Group's diluted earnings per share over the three year performance period (being the financial years ending 31 March 2017, 2018, and 2019). The performance criteria for which the Stretch Awards are based on is the performance of the Group's relative Total Shareholder Return ("TSR") over the three year performance period (being the financial years ending 31 March 2017, 2018, and 2019). The Group's TSR must exceed the median ranking of the TSR of a comparator group comprising the constituents of the FTSE SmallCap for the award to begin vesting. The award will then vest on a straight line basis from 0 per cent to 100 per cent as the Group's TSR ranks from the median TSR up until the upper decile TSR ranking. See the Directors' Remuneration Report within the FY15 Annual Report and Accounts for further detail.

 

No consideration will be paid for the conditional shares upon vesting.

 

For further information please contact:

 

Creston plc

Barrie Brien, Group Chief Executive

+44 (0)20 7930 9757

Kathryn Herrick, Chief Financial Officer

Bell Pottinger

+44 (0)20 3772 2491

Elly Williamson/Lucy Stewart

 

 

About Creston plc

Creston plc (LSE: CRE), incorporating the Creston Unlimited group offer, is a marketing communications group delivering a range of digital technology-based marketing solutions to blue-chip global clients. Encompassing consultants and discipline experts from across the industry and beyond, Creston Unlimited unlocks the power of creative collaboration to realise the opportunities that exist for brands and businesses in today's rapidly evolving world. www.creston.com / www.creston-unlimited.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMMZMLNKGKZG
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.